120491-90-9 Usage
General Description
Diethyl 4-iodo-2,6-pyridinedicarboxylate is a chemical compound with the molecular formula C13H14INO4. It is commonly used as a pharmaceutical intermediate in the synthesis of various drugs and pharmaceuticals. Diethyl 4-iodo-2,6-pyridinedicarboxylate is derived from 2,6-pyridinedicarboxylic acid and is characterized by the presence of an iodine atom at the 4th position of the pyridine ring. The diethyl ester groups in the molecule make it soluble in organic solvents, making it ideal for use in organic synthesis reactions. Additionally, the presence of the ester groups also makes this compound suitable for further derivatization to create new compounds with potential bioactive properties.
Check Digit Verification of cas no
The CAS Registry Mumber 120491-90-9 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,2,0,4,9 and 1 respectively; the second part has 2 digits, 9 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 120491-90:
(8*1)+(7*2)+(6*0)+(5*4)+(4*9)+(3*1)+(2*9)+(1*0)=99
99 % 10 = 9
So 120491-90-9 is a valid CAS Registry Number.
InChI:InChI=1/C11H12INO4/c1-3-16-10(14)8-5-7(12)6-9(13-8)11(15)17-4-2/h5-6H,3-4H2,1-2H3
120491-90-9Relevant articles and documents
An efficient triazole-pyridine-bistetrazolate platform for highly luminescent lanthanide complexes
Di Pietro,Imbert,Mazzanti
, p. 10323 - 10326 (2014)
Two new triazole-pyridine-bistetrazolate ligands were synthesized via a versatile procedure that allows for further derivatization; their corresponding homoleptic tris-ligand nona-coordinated lanthanide complexes are highly luminescent in the solid state and in a PVA polymeric matrix with measured values for the luminescence quantum yield of 70(7) and 98(9)% for Eu III and TbIII, respectively. This journal is the Partner Organisations 2014.
NOVEL 5 OR 8-SUBSTITUTED IMIDAZO [1, 5-a] PYRIDINES AS INDOLEAMINE AND/OR TRYPTOPHANE 2, 3-DIOXYGENASES
-
Paragraph 0226, (2016/10/31)
Disclosed herein are 5 or 8-substituted imidazo[l,5-a]pyridines and pharmaceutical compositions comprising at least one such 5 or 8-substituted imidazo[l,5-a]pyridines, processes for the preparation thereof, and the use thereof in therapy. Disclosed herein are certain 5 or 8- substituted imidazo[l,5-a]pyridines that can be useful for inhibiting indoleamine 2,3- dioxygenase and/or tryptophane 2,3-dioxygenase and for treating diseases or disorders mediated thereby.